Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.63
0.03 (5.00%)
At close: Aug 15, 2025, 3:47 PM
0.61
-2.38%
After-hours: Aug 15, 2025, 03:47 PM EDT
Brainstorm Cell Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.7 | -1.09 | -1.69 | -2.5 | -3.52 | -0.62 | -1.8 | -3.84 | -5.99 | -2.99 | -5.88 | -3.57 | -5.71 | -5.86 | -5.61 | -5.5 | -5.14 |
PEG Ratio | 0.04 | -0.11 | 0.30 | 0.09 | -0.01 | 0.01 | 0.02 | -0.00 | 0.84 | 0.03 | n/a | -0.13 | -0.00 | 0.06 | 0.48 | 0.52 | -0.01 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 40.19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -1.07 | -1.67 | -3.02 | -7.22 | -8.63 | -2.84 | -3.43 | -21.06 | -25.05 | -19.92 | 116.21 | 12.82 | 8.45 | 7.51 | 4.81 | 4.57 | 3.79 |
P/FCF Ratio | -4.9 | -12.36 | -5.55 | -15.12 | -15.64 | -4.2 | -1.38 | -12.06 | -30.41 | -12.92 | -33.25 | -16.36 | -33.12 | -26.2 | -17.89 | -25.76 | -15.23 |
P/OCF Ratio | -4.9 | -12.36 | -5.55 | -15.12 | -15.64 | -4.2 | -1.38 | -12.06 | -30.41 | -12.92 | -33.26 | -16.41 | -33.2 | -26.36 | -18.55 | -25.9 | -15.29 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -9.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.24 | -0.09 | -0.14 | -0.27 | -0.2 | -0.26 | -1.12 | -0.85 | -0.76 | -1.36 | 3.15 | 0.60 | 0.38 | 0.26 | 0.22 | 0.20 | 0.18 |
Quick Ratio | 0.21 | 0.04 | 0.05 | 0.50 | 0.18 | 0.24 | 0.24 | 0.16 | 0.28 | 0.35 | 0.84 | 1.63 | 2.61 | 3.69 | 4.78 | 4.37 | 5.01 |
Current Ratio | 0.21 | 0.04 | 0.05 | 0.50 | 0.18 | 0.24 | 0.24 | 0.16 | 0.28 | 0.35 | 0.84 | 1.63 | 2.61 | 3.69 | 4.78 | 4.37 | 5.01 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -52.22 | n/a | n/a | n/a | -47.72 | n/a | n/a | n/a | n/a | -89.44 | n/a | n/a |
Return on Equity | 0.38 | 0.38 | 0.45 | 0.72 | 0.61 | 1.15 | 0.47 | 1.37 | 1.05 | 1.66 | -4.94 | -0.9 | -0.37 | -0.32 | -0.21 | -0.21 | -0.18 |
Return on Assets | -0.8 | -1.62 | -1.34 | -0.45 | -1.02 | -1.33 | -0.22 | -0.93 | -0.64 | -0.59 | -0.52 | -0.37 | -0.21 | -0.21 | -0.15 | -0.15 | -0.14 |
Return on Invested Capital | 0.54 | 0.48 | 0.68 | 2.07 | 0.85 | 1.34 | -9.05 | 9.24 | 4.44 | -4.56 | -1.19 | -0.6 | -0.27 | -0.25 | -0.16 | -0.16 | -0.15 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.81 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -16.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -16.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -14.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -16.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |